Literature DB >> 4298661

Nicotinamide adenine dinucleotide in the treatment of chronic schizophrenic patients.

A Hoffer, H Osmond.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4298661     DOI: 10.1192/bjp.114.512.915

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  2 in total

1.  NAD+-mediated rescue of prenatal forebrain angiogenesis restores postnatal behavior.

Authors:  Sivan Subburaju; Sarah Kaye; Yong Kee Choi; Jugajyoti Baruah; Debkanya Datta; Jun Ren; Ashwin Srinivasan Kumar; Gabor Szabo; Dai Fukumura; Rakesh K Jain; Abdallah Elkhal; Anju Vasudevan
Journal:  Sci Adv       Date:  2020-10-09       Impact factor: 14.136

2.  NAD+ protects against EAE by regulating CD4+ T-cell differentiation.

Authors:  Stefan G Tullius; Hector Rodriguez Cetina Biefer; Suyan Li; Alexander J Trachtenberg; Karoline Edtinger; Markus Quante; Felix Krenzien; Hirofumi Uehara; Xiaoyong Yang; Haydn T Kissick; Winston P Kuo; Ionita Ghiran; Miguel A de la Fuente; Mohamed S Arredouani; Virginia Camacho; John C Tigges; Vasilis Toxavidis; Rachid El Fatimy; Brian D Smith; Anju Vasudevan; Abdallah ElKhal
Journal:  Nat Commun       Date:  2014-10-07       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.